Pfizer, YaoPharma Sign Global Deal for Oral GLP-1 Candidate Pfizer has signed an exclusive global collaboration and license agreement with YaoPharma, a subsidiary of Shanghai Fosun Pharmaceutical, to advance the development of YP05002, an oral GLP-1 receptor agonist in Phase 1 studies for chronic weight management
[DOI] [PubMed] [Google Scholar] 13.Lee CJ, Song SK, Jeon JH, et al
There are plenty of options for vision correction, from glasses and contacts to surgery, Youssefzadeh points out
Lipo-C With B12 (10 vials/kit) is a lipotropic compound formulation commonly used in wellness and metabolic support programs
A live bacteria enzyme assay for identification of human disease mutations and drug screening
Johns Hospital in Springfield, Illinois, drew on data from the National Institutes of Healths All of Us Research Program, which links electronic health records with Fitbit activity data